White House Warns Staff Over Insider Trading Amid Suspicious Oil Market Bets 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Haiti Election 2025: Voter Registration Delayed Amid Ongoing Security Crisis 
Trump Warns Iran Over Strait of Hormuz Toll Fees Amid Fragile Ceasefire 
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo 
DOJ Launches Antitrust Investigation Into the NFL Over Broadcast Restrictions 
Tabletop particle accelerator could transform medicine and materials science 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
The four types of dementia most people don’t know exist 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Pentagon Defies Court Order on Press Access, Judge Rules 
Israel Strikes Lebanon Amid Iran Ceasefire, UN Condemns Mass Casualties 
Melania Trump Denies Epstein Ties, Calls for Congressional Hearings 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
